Skip to main content
SpringerLink
Log in

Migraine Preventive Medication

  • Chapter
Management of Headache and Headache Medications

  • 96 Accesses

Abstract

Preventive therapy is useful when patients experience more than three moderate to severe headaches per month, or if the abortive medications have not provided sufficient relief. It is an individual decision based upon the person’s willingness to take daily medications, the severity of the headaches, and how much the patient is bothered by the migraine situation. By utilizing daily preventive medicine, patients actually ingest less overall medication because they are not constantly chasing after the headaches with analgesics. The goal of preventive therapy is to decrease the number of migraines by at least 50% to 90% and to lessen the severity of the pain. Patients must realize that we are simply attempting to decrease the overall impact of their migraine headaches, not completely eliminate them. It would be outstanding if the preventive medication completely stopped the headaches from occurring, but this is not realistic with most patients. A compromise must be struck between overmedicating the patient and the number of migraines they suffer; to add more preventive medication in order to eliminate one more migraine every 2 months is usually not worthwhile.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anthony M, Lance JW. Monoamine oxidase inhibition in the treatment of migraine. Arch Neurol. 21:263–268; 1969.

    PubMed  CAS  Google Scholar 

  • Bockstrom T, Hammarbock S. Premenstrual syndrome—psychiatric or gynecological disorder? Headache Quarterly, Cur Tx & Res. 3(2):220; 1992.

    Google Scholar 

  • Belgrade M, Ling L, Schleevogt M, Ettinger M, Ruiz E. Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 39:590–592; 1989.

    PubMed  CAS  Google Scholar 

  • Bell R, Montoya D, Shuaib A, Lee M. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 19:1079–1082; 1990.

    PubMed  CAS  Google Scholar 

  • Blackwell B, Marley E, Price J, Taylor D. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psych. 113:349–365; 1967.

    CAS  Google Scholar 

  • Breslau N, David GD. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia. 12:85–90; 1992.

    PubMed  CAS  Google Scholar 

  • Brewerton TD, George MS. A study of the seasonal variation of migraine. Headache Quarterly, Cur Tx & Res. 2(1):55; 1991.

    Google Scholar 

  • Brewerton TD, George MS. A study of the seasonal variation of migraine. Headache. 30:511–513; 1990.

    PubMed  CAS  Google Scholar 

  • Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 26:168–171; 1986.

    PubMed  CAS  Google Scholar 

  • Calton GJ, Burnett JW. Danazol and migraine. N Engl J Med. 310:721–722; 1984.

    PubMed  CAS  Google Scholar 

  • Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 32:223–228; 1992.

    PubMed  CAS  Google Scholar 

  • Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 36:695–699; 1979.

    PubMed  CAS  Google Scholar 

  • Couch JR, Ziegler DK, Hassanein RS. Amitriptyline in the prophylaxis of migraine. Neurology. 26:121–127; 1976.

    PubMed  CAS  Google Scholar 

  • Couch JR. Placebo effect and clinical trials in migraine therapy. Neuroepidemiology. 6:178–185; 1987.

    PubMed  Google Scholar 

  • Couturier EGM, Hering R, Steiner TJ. Weekend attacks in migraine patients: caused by caffeine withdrawal? Cephalalgia. 12:99–100; 1992.

    PubMed  CAS  Google Scholar 

  • Cmickshank JM, Neil-Dwyer G. Beta-blocker brain concentrations in man. Eur J Clin Pharmacol. 28(Suppl):21–23; 1985.

    Google Scholar 

  • Curran DA, Hinterberger H, Lance JW. Methysergide. Rs Clin Stud Headache. 1:74–122; 1967.

    CAS  Google Scholar 

  • Dennerstein L, Laby B, Burrows GD, Hyman GJ. Headache and sex hormone therapy. Headache. 18:146–153; 1978.

    PubMed  CAS  Google Scholar 

  • Diamond ML. Emergency department treatment of the headache patient. Headache Quarterly, Cur Tx & Res. 3(Suppl l):28–33; 1992.

    Google Scholar 

  • Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache. 15:282–287; 1976.

    PubMed  CAS  Google Scholar 

  • Diamond S. Menstrual migraine and non-steroidal anti-inflammatory agents. Headache. 24:52; 1984.

    PubMed  CAS  Google Scholar 

  • Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propranolol in the treatment of migraine. Headache. 22:268–271; 1982.

    PubMed  CAS  Google Scholar 

  • Diamond S, Solomon GD, Freitag FG, Mehta N. Fenoprofen in the prophylaxis of migraine: a double-bhnd, placebo controlled study. Headache. 27:246–249; 1987.

    PubMed  CAS  Google Scholar 

  • Diamond S, Solomon GD. Pharmacologic treatment of migraine. Rat Drug Ther. 22:1–5; 1988.

    CAS  Google Scholar 

  • Diamond S, Solomon GD, Freitag FG, Mehta ND. Long-acting propranolol in the prophylaxis of migraine. Headache. 27:70–72; 1987.

    PubMed  CAS  Google Scholar 

  • Dimsdale JE, Newton RP. Cognitive effects of beta blockers. Headache Quarterly, Cur Tx & Res. 3(3):347; 1992.

    Google Scholar 

  • Drummond PD. Effectiveness of methysergide in relation to clinical features of migraine. Headache. 25:145–146; 1985.

    PubMed  CAS  Google Scholar 

  • Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 31:298–301; 1991.

    PubMed  CAS  Google Scholar 

  • Fuller GN, Guiloff RJ. Propranolol in acute migraine: a controlled study. Cephalalgia. 10:229–233; 1990.

    PubMed  CAS  Google Scholar 

  • Gallagher RM. Emergency treatment of intractable migraine. Headache. 26:74–75; 1986.

    PubMed  CAS  Google Scholar 

  • Gilbert RM, Marshman JA, Schweider M, Berg R. Caffeine content of beverages as consumed. Can Med Assoc J. 114:205–208; 1976.

    PubMed  CAS  Google Scholar 

  • Goadsby PJ, Zagami AS, Donnan GA, et al. Oral sumatriptan in acute migraine. Headache Quarterly, Cur Tx & Res. 3(2):212; 1992.

    Google Scholar 

  • Goldstein J. Ergot pharmacology and alternative delivery systems for ergotamine derivatives. Headache Quarterly, Cur Tx Res. 3(3):345; 1992.

    Google Scholar 

  • Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. J Neurol Neuro- surg Psych. 36:684–690; 1973.

    CAS  Google Scholar 

  • Graham J. Cardiac and pulmonary fibrosis during methysergide therapy for headache. Am J Med Sei. 254:1–12; 1967.

    CAS  Google Scholar 

  • Greenberg DA. Calcium channel antagonists and the treatment of migraine. Clin Neuropharmacol. 9:311–328; 1986.

    PubMed  CAS  Google Scholar 

  • Greenberg DA. Calcium channel and calcium channel antagonists. Ann Neurol. 21:317–330; 1987.

    PubMed  CAS  Google Scholar 

  • Grotemeyer K-H, Scharafinski H-W, Husstedt IW. AcetylsaUcylic acid vs. metoprolol in migraine prophylaxis—a double-blind cross-over study. Headache. 30:639–641; 1990.

    PubMed  CAS  Google Scholar 

  • Hakkarainen H, Alionen H. Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache. 22:10–12; 1982.

    PubMed  CAS  Google Scholar 

  • Hakkarainen H, Vapaatolo H, Gothoni G. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet. 2:326–327; 1979.

    PubMed  CAS  Google Scholar 

  • Harden RN, Carter TD, Gilman CS. Ketorolac in acute headache management. Headache. 31:463–464; 1991.

    PubMed  CAS  Google Scholar 

  • Hauck AJ, Edwards WD, Danielson GK, Mullany CJ, Bresnahan DR. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Headache Quarterly, Cur Tx & Res. 2(1):58; 1991.

    Google Scholar 

  • Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia. 12:81–84; 1992.

    PubMed  CAS  Google Scholar 

  • Hokkanen E, Waltimo O, Kallanranta T. Toxic effects of ergotamine used for migraine. Headache. 18:95–98; 1978.

    PubMed  CAS  Google Scholar 

  • Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache. 31:333–340; 1991.

    PubMed  CAS  Google Scholar 

  • Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: A meta-analytic review of clinical trials. Headache Quarterly, Cur Tx & Res. 2(1):59; 1991.

    Google Scholar 

  • Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia. 5:5–10; 1985.

    PubMed  CAS  Google Scholar 

  • Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of IV prochlorperazine for the treatment of acute headache. JAMA. 261:1174–1176; 1989.

    PubMed  CAS  Google Scholar 

  • Jonsdottir M, Meyer JS, Rogers RL. Efficacy, side effects and tolerance compared during headache treatment with three different calcium blockers. Headache. 27:364–369; 1987.

    PubMed  CAS  Google Scholar 

  • Joseph R, Steiner T, Schultz L, Rose CF. Platelet activity and selective beta- blockage in migraine prophylaxis: a case for preferring betal adrenoceptor blockers. Stroke. 19:704–708; 1988.

    PubMed  CAS  Google Scholar 

  • Klapper JA, Stanton J. Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches. Headache Quarterly, Cur Tx & Res. 3(3):345; 1992.

    Google Scholar 

  • Klapper JA. Emergency management of benign headaches. Headache Quarterly, Cur Tx & Res. 3(2):160–163; 1992.

    Google Scholar 

  • Klapper J, Stanton J. A comparison of dihydroergotamine, dexamethasone and placebo in the treatment of acute migraine headache. Cephalalgia. 11(Suppl 11):159–161; 1991.

    Google Scholar 

  • Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 12:169–171; 1992.

    PubMed  CAS  Google Scholar 

  • Koella WP. CNS-related side effects of beta-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol. 28:55–63; 1985.

    PubMed  CAS  Google Scholar 

  • Krause KH, Bleicher MA. DHE nasal spray in the treatment of migraine attacks. Cephalagia. 5(Suppl 3):138–139; 1985.

    Google Scholar 

  • Kudrow L. The relationship of headache frequency to hormonal use in migraine. Headache. 15:36–40; 1975.

    PubMed  CAS  Google Scholar 

  • Lader M. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors. J Clin Psychiatry. 44:20–24; 1983.

    PubMed  CAS  Google Scholar 

  • Lance JW. The pharmacotherapy of migraine. Med J Aust. 144:85–88; 1986

    PubMed  CAS  Google Scholar 

  • Laska EM, Sunshine A, Mueller F, et al. Caffeine as an analgesic adjuvant. JAMA. 251:1711–1718; 1984.

    PubMed  CAS  Google Scholar 

  • Lichten EM, Bennett RS, Whitty AJ, Daoud Y. Efficacy of danazol in the control of hormonal migraine. Headache Quarterly, Cur Tx & Res. 3(2):219; 1992.

    Google Scholar 

  • Lindegaard KF, Ovrelid L, Sjaastad O. Naproxen in the prevention of migraine attacks. A double-blind placebo-controlled crossover study. Headache. 20:96–98; 1980.

    PubMed  CAS  Google Scholar 

  • Magos AL, Zilkha KJ, Studd JWW. Treatment of menstrual migrine by oestradiol implants. J Neurol Neurosurg Psych. 46:1044–1046; 1983.

    CAS  Google Scholar 

  • Markley HG, Cheronis JCD, Piepho RW. Verapamil in prophylactic therapy of migraine. Neurology. 34:963–976; 1984.

    Google Scholar 

  • Massiou H, Sermrier D, Lasserre O, Bousser M-G. Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo. Cephalalgia. 11:59–63; 1991.

    PubMed  CAS  Google Scholar 

  • Mathew NT. Prophylaxis of migraine and mixed headache: a randomized controlled study. Headache. 21:105–109; 1981.

    PubMed  CAS  Google Scholar 

  • Mathew NT, Reuveni U, Perez F. Transformed or evolutive mipaine. Headache. 27:102–106; 1987.

    PubMed  CAS  Google Scholar 

  • McEwen J, O’Connor H, Dinsdale H. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med. 16:758–763; 1987.

    PubMed  CAS  Google Scholar 

  • Medina JL, Diamond S. The role of diet in migraine. Headache. 18:31–34; 1978.

    PubMed  CAS  Google Scholar 

  • Meyer JS. Calcium channel blockers in the prophylactic treatment of vascular headache. Ann Intern Med. 102:395–397; 1985.

    PubMed  CAS  Google Scholar 

  • Meyer JS, Do well R, Mathew N, Hardenburg J. Clinical and hemodynamic treatment of vascular headaches with verapamil. Headache. 24:313–321; 1984.

    PubMed  CAS  Google Scholar 

  • Mitchelson F. Pharmacological agents affecting emesis, a review (Part I). Headache Quarterly, Cur Tx & Res. 3(3):347; 1992.

    Google Scholar 

  • Mondell BE. Office management of acute headache. Headache Quarterly, Cur Tx & Res. 3(Suppl l):4–9; 1992.

    Google Scholar 

  • Monro J, Brostoff J, Carini C, Zilkha K. Food allergy in migraine: study of food allergy and RAST. Lancet. 2:1; 1980.

    PubMed  CAS  Google Scholar 

  • Nestvold K. Naproxen and naproxen sodium in acute migraine. Cephalalgia. 6(Suppl 4):81–84; 1986.

    PubMed  Google Scholar 

  • Neuman M, Demarez JP, Harmey JL, Le Bastard B, Cauquil J. Prevention of migraine attacks through the use of dihydroergotamine. Int J Clin Pharmacol Res. 6:11–13; 1986.

    PubMed  CAS  Google Scholar 

  • Olerud B, Gustavsson C-L, Furberg B. Nadolol and propranolol in migraine management. Headache. 26:490–493; 1986.

    PubMed  CAS  Google Scholar 

  • Olesen J. Role of calcium entry blockers in the prophylaxis of migraine. Eur Neurol. 25(Suppl l):72–79; 1986b.

    PubMed  Google Scholar 

  • Orlando RC, Moyer P, Barnett TB. Methysergide therapy and constrictive pericarditis. Ann Intern Med. 88:213–214; 1978.

    PubMed  CAS  Google Scholar 

  • Pearce I, Frank GJ, Pearce JMS. Ibuprofen compared with paracetamol in migraine. Practitioner. 227:465–467; 1983.

    PubMed  CAS  Google Scholar 

  • Peatfield R. Drugs and the treatment of migraine. Trends Pharmacol Sei. 9:141–145; 1988.

    CAS  Google Scholar 

  • Peatfield RC, Fozard JR, Rose FC. Drug treatment of migraine. In: Handbook of Clinical Neurology, Vol. 48. FC Rose, ed. Amsterdam; Elsevier Science Publishing: 173–216; 1986.

    Google Scholar 

  • Peroutka S. Sumatriptan in acute migraine: pharmacology and review of world experience. Headache. 30(Suppl 2):554–560; 1990.

    PubMed  Google Scholar 

  • Peroutka S, Allen GS. The calcium antagonist properties of cyproheptadine: imphcations for antimigraine action. Neurology. 34:304–309; 1984.

    PubMed  CAS  Google Scholar 

  • Peroutka SJ, Banghart SB, Allen GS. Relative potency and selectivity of calcium channel antagonists used in the treatment of migraine. Headache. 24:55–58; 1984.

    PubMed  CAS  Google Scholar 

  • Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med. (Suppl June 14):36–42; 1983.

    Google Scholar 

  • Powles TJ. Prevention of migrainous headache by tamoxifen. Lancet. 2:1344; 1986.

    PubMed  CAS  Google Scholar 

  • Pradaher A, Rancurel G, Dordain G, et al. Acute migraine attack therapy— comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia. 5:107–113; 1985.

    Google Scholar 

  • Primavera III JP, Kaiser RS. Non-pharmacological treatment of headache: is less more? Headache. 32:393–395; 1992.

    PubMed  Google Scholar 

  • Rapaport A, Weeks R, Sheftell F, et al. Analgesic rebound headache: theoretical and practical implications. Cephalalgia. 5(Suppl 3):448–449; 1985.

    Google Scholar 

  • Rapoport AM. The diagnosis of migraine and tension-type headache, then and now. Headache Quarterly, Cur Tx & Res. 3(3):348; 1992.

    Google Scholar 

  • Rapoport AM, Silberstein SD. Emergency treatment of headache. Headache Quarterly, Cur Tx & Res. 3(3):346; 1992.

    Google Scholar 

  • Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 36:995–997; 1986.

    PubMed  CAS  Google Scholar 

  • Raskin NH. Pharmacology of migraine. Annu Rev Pharmacol Toxicol. 21:463–478; 1981.

    PubMed  CAS  Google Scholar 

  • Raskin N. Treatment of status migranosus: the American experience. Headache. 30(Suppl 2):550–553; 1990.

    PubMed  Google Scholar 

  • Raskin NH, Schwartz RK. Interval therapy of migraine; long-term results. Headache. 20:336–340; 1980.

    PubMed  CAS  Google Scholar 

  • Riopleel RJ, McCans JL. A pilot study of the calcium antagonist diltiazem in migraine syndrome prophylaxis. Can J Neurol Sei. 9:269; 1982.

    Google Scholar 

  • Robbins L, Remmes A. Outpatient Repetitive Intravenous Dihydroergotamine. Headache. 32, No. 9:455–458; 1992.

    PubMed  CAS  Google Scholar 

  • Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Ann Neurol. 13:92–93; 1983.

    PubMed  CAS  Google Scholar 

  • Ross-Lee L, Headlewood V, Tyrer JH, Eadie MJ. Aspirin treatment of migraine attacks: plasma drug level data. Cephalalgia. 2:9–14; 1982b.

    PubMed  CAS  Google Scholar 

  • Ryan Sr. RE Comparative study of nadolol and propranolol in prophylactic treatment of migraine. Am Heart J. 108:1156–1158; 1984.

    PubMed  Google Scholar 

  • Saadah HA. Abortive headache therapy with intramuscular dihydroergotamine. Headache Quarterly, Cur Tx & Res. 3(3):345; 1992.

    Google Scholar 

  • Saadah HA. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache Quarterly, Cur Tx & Res. 3(3):345; 1992.

    Google Scholar 

  • Saadah HA. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache. 32:143–146; 1992

    PubMed  CAS  Google Scholar 

  • Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache. 30:705–709; 1990.

    PubMed  CAS  Google Scholar 

  • Sargent J, Solbach F, Coyne L, et al. Results of a controlled, experimental outcome study of nondrug treatments for the control of migraine headaches. J Behav Med. 9:291–323; 1986.

    PubMed  CAS  Google Scholar 

  • Sargent JD, Baumel B, Peters K, et al. Aborting a migraine attack: naproxen sodium vs ergotamine plus caffeine. Headache. 28:263–266; 1988.

    PubMed  CAS  Google Scholar 

  • Schiffman S, Buckley CE, Sampson HA, et al. Aspartame and susceptibility to headache. N Engl J Med. 317:1181–1185; 1987.

    PubMed  CAS  Google Scholar 

  • Schulman EA, Silberstein SD. Symptomatic and prophylactic treatment of migraine and tension-type headache. Neurology. 42(Suppl 2):16–21; 1992.

    PubMed  CAS  Google Scholar 

  • Scopp AL. MSG and hydrolyzed vegetable protein induced headache: review and case studies. Headache. 31:107–110; 1991.

    PubMed  CAS  Google Scholar 

  • Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 23:23–32; 1960.

    PubMed  CAS  Google Scholar 

  • Silberstein SD. Appropriate use of abortive medication in headache treatment. Headache Quarterly, Cur Tx & Res. 3(2):212; 1992.

    Google Scholar 

  • Silberstein SD. The role of sex hormones in headache. Headache Quarterly, Cur Tx & Res. 3(3):349; 1992.

    Google Scholar 

  • Silberstein SD. Advances in understanding the pathophysiology of headache. Neurology. 42(Suppl 2):6–10; 1992.

    PubMed  CAS  Google Scholar 

  • Silberstein SD. The role of sex hormones in headache. Neurology. 42(Suppl 2):37–42; 1992.

    PubMed  CAS  Google Scholar 

  • Silberstein SD. Evaluation and emergency treatment of headache. Headache. 32:396–407; 1992.

    PubMed  CAS  Google Scholar 

  • Silberstein SD, Schuhnan EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 30:334–339, 1990.

    PubMed  CAS  Google Scholar 

  • Solomon GD. Management of the headache patient with medical illness. Clin J Pain. 5:95–99; 1989.

    PubMed  CAS  Google Scholar 

  • Solomon GD, Griffith Steel MD, Spaccavento LJ. Verapamil prophylaxis of migraine. JAMA. 250:2500–2502; 1983.

    PubMed  CAS  Google Scholar 

  • Sommerville BW. Estrogen withdrawal migraine. 1. Duration of exposure and attempted prophylaxis by premenstrual estrogen administration. Neurology. 25:239–244; 1975.

    Google Scholar 

  • Spiegel K, Kalb R, Pasternak GW. Analgesic activity of tricyclic antidepressants. Ann Neurol. 13:462–465; 1983.

    PubMed  CAS  Google Scholar 

  • Steiner TJ, Joseph R. Practical experience of beta-blockage in migraine: a personal view. Postgrad Med J. 60(Suppl 2):56–60; 1984.

    PubMed  Google Scholar 

  • Stensrud P, Sjaastad O. Clinical trial of a new antibradykinin, anti-inflammatory drug, ketoprofen, in migraine prophylaxis. Headache. 14:96–100; 1974.

    PubMed  CAS  Google Scholar 

  • Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. Headache Quarterly, Cur Tx & Res. 3(2):219; 1992.

    Google Scholar 

  • Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 325:316–321; 1991.

    Google Scholar 

  • Tek D, McClellan D, Olshaker M, Allen C, Arthur D. A prospective, double- bhnd study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 19:1083–1087; 1990.

    PubMed  CAS  Google Scholar 

  • Tfelt-Hansen P. Efficacy of Beta-blockers in migraine. Cephalalgia. 6(Suppl 5): 15–24; 1986.

    PubMed  Google Scholar 

  • Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, et al. A double-blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiat. 43:369–371; 1980.

    PubMed  CAS  Google Scholar 

  • Tfelt-Hansen P, Paalzow L, Ibraheem JJ. Bioavailabihty of sublingual ergotamine. Br J Clin Pharmacol. 13:239–240; 1982b.

    PubMed  CAS  Google Scholar 

  • Treves TA, Streiffler M, Korczyn AD. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache. 32:280–282; 1992.

    PubMed  CAS  Google Scholar 

  • Tucker JS, Whalen RE. Premenstrual syndrome. Headache Quarterly, Cur Tx & Res. 3(3):349; 1992.

    Google Scholar 

  • Turkewitz LJ, Casaly JS, Dawson GA, Wirth O. Phenelzine therapy for headache patients with concomitant depression and anxiety. Headache. 32:203–208; 1992.

    PubMed  CAS  Google Scholar 

  • Vincent FM. Migraine responsive to danazol. Neurology 35:618; 1985.

    PubMed  CAS  Google Scholar 

  • Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J. 54:98–102; 1978.

    PubMed  CAS  Google Scholar 

  • Ward TN, Scott G. Dihydroergotamine suppositories in a headache clinic. Headache. 31:465–466; 1991.

    PubMed  CAS  Google Scholar 

  • Welch KM A, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology. 35:1304–1310; 1985.

    PubMed  CAS  Google Scholar 

  • Wilkinson M. Treatment of acute migraine: the British experience. Headache. 30(Suppl 2):545–549; 1990.

    PubMed  Google Scholar 

  • Wood AJJ. Pharmacologic differences between beta blockers. Am Heart J. 108:1070–1076; 1984.

    PubMed  CAS  Google Scholar 

  • Yardi Y, Rabey JM, Streifler M. Migraine attacks: alleviation by an inhibitor of prostaglandin synthesis and action. Neurology. 26:447–450, 1976.

    Google Scholar 

  • Zahavi I, Chagnac A, Hering R, et al. Prevalence of Raynaud’s phenomenon in patients with migraine. Arch Intern Med. 144(4):742–744; 1984.

    PubMed  CAS  Google Scholar 

  • Ziegler DK. Headache and migraine. Headache Quarterly, Cur Tx & Res. 3(3): 340; 1992.

    Google Scholar 

  • Ziegler DK, Elis DJ. Naproxen in prophylaxis of migraine. Arch Neurol. 42:582–584; 1985.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rush Medical College, Chicago, IL, USA

    Lawrence D. Robbins M.D. (Assistant Professor of Neurology, Clinical Assistant Professor of Neurology, Director)

  2. University of Illinois, Chicago, IL, USA

    Lawrence D. Robbins M.D. (Assistant Professor of Neurology, Clinical Assistant Professor of Neurology, Director)

  3. Robbins Headache Clinic, Northbrook, IL, USA

    Lawrence D. Robbins M.D. (Assistant Professor of Neurology, Clinical Assistant Professor of Neurology, Director)

Authors
  1. Lawrence D. Robbins M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Robbins, L.D. (1994). Migraine Preventive Medication. In: Management of Headache and Headache Medications. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-0195-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-0195-0_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-0197-4

  • Online ISBN: 978-1-4684-0195-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation